@prefix biolink: . @prefix ns1: . @prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix dct: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { biolink:category biolink:Disease . sub:association rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; rdfs:label "Sevoflurane, USP can cause malignant hyperthermia. It should not be used in patients with known sensitivity to sevoflurane, USP or to other halogenated agents nor in patients with known or suspected susceptibility to malignant hyperthermia."; biolink:provided_by ; biolink:relation schema:MedicalContraindication . biolink:category biolink:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "UZgSBiZY/Y7nCJHlf04/2A8B3Hc4+N5oXDD5AppxPhcjVe2eIthzVsbP7RAYKepZ4ERAdxqHuBN2vSAR+LsHDO3epzif8xyYUXjvls7ihsMlJnELyLBzbCHCTRMdRe4ff2q68scuSAl1Nt4P5P/KcpF36obTsQmKOPCB0YCi4EA="; npx:hasSignatureTarget this: . this: dct:created "2021-08-25T14:16:17.389+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; ns1:wasCreatedFromProvenanceTemplate ; ns1:wasCreatedFromPubinfoTemplate ; ns1:wasCreatedFromTemplate . }